August 10, 2016
Sponsored by Colder Products Company
Standardizing equipment in biopharmaceutical production streamlines operations, saving end users time and money. An area ripe for standardization is the use of genderless connections, those in which the connector halves are identical in design. Historically, single-use connections have involved male and female halves, but using two different parts can create several inefficiencies and complications, such as
Increased ordering complexity
Greater risk of specifying the wrong system or connection, resulting in downtime and last-minute adjustments
Longer lead times
Increased stocking requirements
By standardizing single-use genderless connectors, end users can accomplish more with fewer finished goods, save time, reduce overhead costs, and get their biopharmaceutical products to market more efficiently. Benefits include
Streamlined operations with easy to use, robust sterile connections
More flexibility and decreased bottlenecks with on-site connector assembly
Reduced overhead costs, freeing up capital for other projects.
Overall, genderless connector standardization will help bioprocessing facilities simplify their operations and implement single-use technology to its full potential.
Todd Andrews is the global sales and business development manager, Bioprocessing at CPC, 1001 Westgate Drive, St. Paul, MN 55114; 1-651645-0091; [email protected].
You May Also Like
